Work

Safety and immunogenicity of a cytomegalovirus (CMV) recombinant glycoprotein B (gB) vaccine in combination with polyacrylate or an emulsion-based adjuvants

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Vaccine

DOI: 10.1016/j.vaccine.2026.128553

Authors: Sylvie Pichon, Isabelle Bruyère, Stéphane Janicot, Widad Silhadi, Sophie Pallardy, Ada-Maria Minutello, Yves Donazzolo, Mathilde Latreille, Laurent Beloeil, Nathalie Garcon, Anke Pagnon, Frédérique Jantet-Blaudez, Fabienne Piras-Douce

Institutions: Sanofi (France), Eurofins (France), BIOASTER

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Sanofi, Agence Nationale de la Recherche

Award: G3392039740

OpenAlex ID: W7151996367

FWCI: 3.503

Cites: 33

Cited by: 1

Related to: 10